Executive Director, Corporate Strategy & Intelligence
Recursion
August 19, 2026
Remote friendly (New York, NY)
United States
Corporate Functions
In This Role, You Will
- Lead commercial assessment, strategic fit analyses, and the design of competitive moats for pipeline assets (early validation through late-stage), integrating epidemiology, patient segmentation, competitive positioning, pricing/market access dynamics, and revenue forecasts to inform go/no-go, prioritization, and partnering decisions.
- Own end-to-end competitive intelligence for specific initiatives and BD opportunities using agentic approaches and advanced analytics/modeling to deliver timely, decision-grade insights on competitors, therapeutic area dynamics, evolving platform technologies, and the drug discovery ecosystem.
- Grow and refine a real-time intelligence system synthesizing signals from clinical data, regulatory filings, investor disclosures, scientific publications, partner pipelines, and industry events; preempt market disruptions and identify white space.
- Collaborate with functional leaders and the C-suite to translate competitive/commercial intelligence into corporate strategy, long-range planning, and actionable narratives for portfolio prioritization, platform positioning, partnership strategy, and growth vectors.
The Experience You’ll Need
- Advanced degree in a scientific/quantitative/business field required; MBA, PhD, MD, or equivalent strongly preferred.
- 10+ years in competitive intelligence, pipeline differentiation strategy, forecasting/demand estimation, and quantitative/qualitative market research; corporate strategy or BD in pharma/biotech/life sciences consulting.
- Deep knowledge of drug development landscape (therapeutic area dynamics, clinical-stage competitive assessments, regulatory strategy, market access).
- Proven track record delivering commercial assessments/strategic analyses influencing pipeline prioritization, partnership strategy, and go/no-go decisions.
- Advantage: experience with AI-enabled drug discovery/platform biotechs; ability to translate platform capabilities into commercial/competitive narratives.
- Experience advising business development transactions (licensing, co-development, M&A) in a strategic/competitive intelligence context.
- Strong financial/analytical acumen (commercial models, scenario analyses, valuation frameworks).
- Exceptional communication/executive presence.
Compensation/Benefits
- Estimated annual base salary range: $287,980–$346,060; eligible for annual bonus, equity compensation, and comprehensive benefits.
- Lead commercial assessment, strategic fit analyses, and the design of competitive moats for pipeline assets (early validation through late-stage), integrating epidemiology, patient segmentation, competitive positioning, pricing/market access dynamics, and revenue forecasts to inform go/no-go, prioritization, and partnering decisions.
- Own end-to-end competitive intelligence for specific initiatives and BD opportunities using agentic approaches and advanced analytics/modeling to deliver timely, decision-grade insights on competitors, therapeutic area dynamics, evolving platform technologies, and the drug discovery ecosystem.
- Grow and refine a real-time intelligence system synthesizing signals from clinical data, regulatory filings, investor disclosures, scientific publications, partner pipelines, and industry events; preempt market disruptions and identify white space.
- Collaborate with functional leaders and the C-suite to translate competitive/commercial intelligence into corporate strategy, long-range planning, and actionable narratives for portfolio prioritization, platform positioning, partnership strategy, and growth vectors.
The Experience You’ll Need
- Advanced degree in a scientific/quantitative/business field required; MBA, PhD, MD, or equivalent strongly preferred.
- 10+ years in competitive intelligence, pipeline differentiation strategy, forecasting/demand estimation, and quantitative/qualitative market research; corporate strategy or BD in pharma/biotech/life sciences consulting.
- Deep knowledge of drug development landscape (therapeutic area dynamics, clinical-stage competitive assessments, regulatory strategy, market access).
- Proven track record delivering commercial assessments/strategic analyses influencing pipeline prioritization, partnership strategy, and go/no-go decisions.
- Advantage: experience with AI-enabled drug discovery/platform biotechs; ability to translate platform capabilities into commercial/competitive narratives.
- Experience advising business development transactions (licensing, co-development, M&A) in a strategic/competitive intelligence context.
- Strong financial/analytical acumen (commercial models, scenario analyses, valuation frameworks).
- Exceptional communication/executive presence.
Compensation/Benefits
- Estimated annual base salary range: $287,980–$346,060; eligible for annual bonus, equity compensation, and comprehensive benefits.